ENN-0403

N/A

Report date: 2024/09/23 20:00:34
NME

Base Information

Drug NameENN-0403
Drug Alias NameENN0403ENN-0403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaAcute Kidney InjuryMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYinuo (Zhejiang) Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai EnnovaBio Pharmaceuticals Co LtdYinuo (Zhejiang) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaAcute Kidney InjuryMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A